how to prevent muscle loss on tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial 💊 Could a new medication

Tirzepatide does all of that as a GIP/GLP-1 dual agonist and additionally engages the GIP receptor, adding a second incretin mechanism

Comprehensive Ivim Membership: Expert Care and Unmatched Support Ivim Healths membership provides patients with holistic, tailored care throughout their weight loss journey

Stop using Wegovy and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting

While clinical trials often show strong benefits, real-world results can vary

Williams RL, Courtneidge SA, Wagner EF (1998) Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene